Data-driven insights that help companies navigate the changing retail and technology landscape. LEARN MORE
Company Earnings Update

CVS Health (NYSE: CVS) 2Q19 Results: Narrows Profit and Earnings Outlook on Aetna Strength

#
Coresight Research

Key Points

  • CVS Health reported 2Q19 revenues of $63.4 billion, up 35.2% year over year and ahead of the consensus estimate. Diluted EPS was $1.49, versus a loss per share of $2.52 in 2Q18.
  • CVS closed its acquisition of Aetna in November 2018 and was the primary growth driver during the quarter, along with increased volumes and brand name drug price inflation.
  • For FY19, CVS narrowed its adjusted EPS guidance range to $6.89-7.00 from $6.75-6.90.

Please Log In to read the full report. Not a member? Register for a free user account.

Other research you may be interested in:

×